Additional file 1: of Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study

Table S1. Characteristics of the 423 children in the Nordic juvenile idiopathic arthritis cohort at baseline. (PDF 134 kb

Additional file 3: of Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study

Figure S1. Receiver operating characteristic (ROC) curves for the four unfavorable clinical outcomes in the validation sets, but for models constructed without using blood samples as predictors. The colored lines are the mean ROC curves for the 100 different realizations of the partitioning of the cohort into training sets and validation sets (thin gray curves). (a) Not in remission. (b) Childhood Health Assessment Questionnaire (CHAQ) >0. (c) Physical Summary Score (PhS) <40. (d) Juvenile Arthritis Damage Index-Articular (JADI-A) >0. (PDF 435 kb

Additional file 2: of Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study

Table S2. Medications given before the baseline study visit. (PDF 108 kb

Additional file 1 of Serum and salivary inflammatory biomarkers in juvenile idiopathic arthritis—an explorative cross-sectional study

Additional file 1: Supplemental Table S1. Comorbidities and co-medication in the study groups. The table shows the number of individuals with co-existing health conditions and medication unrelated to juvenile idiopathic arthritis. It also shows the health conditions and medication of the control group